CGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Made

 
• By David Wild

Technical challenges and lackluster investor sentiment about the near-term commercial potential of cell and gene therapies in neurological disorders may be holding the field back.

3D illustration male nervous system, medical concept. - Illustration
The CNS Remains A Challenging Target For Cell and Gene Therapy • Source: Shutterstock

More from Innovation

More from In Vivo